XCancer

A Clinical Trial on Pharmacokinetics and Radiation Dosimetry, Safety and Preliminary Efficacy Evaluation of Lutetium [177Lu]-FAP-75 for the Treatment of Patients With Advanced Solid Tumors

Description:

To explore the safety, tolerability, initial efficacy, pharmacokinetic profile and radiation dosimetry of lutetium [177Lu]-FAP-75 in the treatment of patients with advanced solid tumors.

Sponsor:

Fudan University

Phase:

Phase 1

Government Study Link:

NCT06553846 - Click here to see study on

ClinicalTrials.gov

Isotope(s):
Target(s):
  • FAP